Medicine and Dentistry
Brugada Syndrome
100%
Pulmonary Hypertension
76%
Ventricular Fibrillation
68%
Heart Failure
63%
Cardiac Sarcoidosis
48%
Electrocardiogram
45%
Coronary Artery Disease
40%
Atrial Septal Defect
34%
Repolarization
25%
Cardiovascular System
22%
Faintness
22%
Heart Muscle Biopsy
21%
Right Bundle Branch Block
20%
Lung Transplantation
20%
Implantable Automatic Defibrillator
20%
Coronary Computed Tomography Angiography
19%
Percutaneous Coronary Intervention
18%
Hypertrophic Cardiomyopathy
18%
Ventricular Tachycardia
18%
Cardiovascular Disease
18%
Hazard Ratio
17%
Biological Marker
17%
Chronic Kidney Disease
17%
Carvedilol
16%
Vein Anastomosis
16%
Cystatin C
16%
Subcutaneous Implantable Cardioverter Defibrillator
16%
Dilated Cardiomyopathy
15%
Atrial Fibrillation
15%
Ventricular Outflow Tract
15%
Shear Wave Elastography
14%
Computed Tomography Angiography
14%
Multidetector Computed Tomography
13%
Diagnosis
13%
Cardiac Muscle Cell
13%
Nonalcoholic Fatty Liver
13%
Oxidative Stress
13%
Computer Assisted Tomography
12%
Ejection Fraction
12%
Clinical Significance
11%
Lung Artery Pressure
11%
Left Coronary Artery
11%
Pulmonary Artery Aneurysm
11%
Torsade Des Pointes
11%
Patient with Type 2 Diabetes
11%
Prevalence
11%
Recurrent Disease
10%
Transdermal Patch
10%
Non Small Cell Lung Cancer
10%
Patent Foramen Ovale
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
98%
Heart Ventricle Fibrillation
46%
Brugada Syndrome
44%
Coronary Artery Disease
44%
Prostacyclin
33%
Heart Failure
32%
Atrial Fibrillation
27%
Heart Arrhythmia
26%
Randomized Controlled Trial
26%
Icosapentaenoic Acid
23%
Coronary Artery Calcification
22%
Heart Muscle Injury
21%
Hypertrophic Cardiomyopathy
21%
Luseogliflozin
21%
Endothelial Dysfunction
18%
Voglibose
17%
Cardiac Sarcoidosis
16%
Fatty Acid Binding Protein 4
16%
Acute Heart Failure
16%
Ezetimibe
16%
Carvedilol
15%
Heart Ventricle Arrhythmia
15%
Nicorandil
14%
Amiodarone
14%
Diabetes Mellitus
14%
Adverse Event
14%
Chronic Kidney Failure
13%
Cardiovascular Disease
13%
Stable Angina Pectoris
13%
Statin (Protein)
13%
Antiarrhythmic Agent
12%
Nonalcoholic Fatty Liver
12%
Brain Natriuretic Peptide
12%
Myocarditis
12%
Biological Marker
11%
Monocrotaline
11%
Heart Infarction
11%
Metabolic Syndrome X
11%
Ischemic Heart Disease
11%
Heart Failure with Preserved Ejection Fraction
11%
Non Insulin Dependent Diabetes Mellitus
11%
4 Hydroxynonenal
10%
Pemafibrate
10%
ST Segment Elevation Myocardial Infarction
10%
Restenosis
10%
Bepridil
10%
Heart Ventricle Hypertrophy
10%
Artery Calcification
10%
Cystatin C
10%
Hypertriglyceridemia
10%
Keyphrases
Brugada Syndrome
38%
Ventricular Fibrillation
29%
Cardiac Sarcoidosis
27%
Pemafibrate
16%
Remote Ischemic Preconditioning
16%
Shear Wave Dispersion Slope
16%
Pulmonary Hypertension
14%
Fragmented QRS (fQRS)
13%
Heart Failure
13%
Isolated Cardiac Sarcoidosis
12%
Confidence Interval
12%
Ventricular Arrhythmia
12%
Protective Effect
12%
Elective Percutaneous Coronary Intervention
12%
Syncope
11%
Hypertrophic Cardiomyopathy
11%
Extracardiac
11%
Pulmonary Arterial Hypertension
10%
Epoprostenol
10%
K-877
10%
Bisoprolol Transdermal Patch
10%
Clinical Significance
10%
Patients with Diabetes Mellitus
10%
Coronary Artery Calcification
10%
Primary Pulmonary Hypertension
10%
Luseogliflozin
10%
Chronic Kidney Disease
10%
Idiopathic Dilated Cardiomyopathy
10%
Patent Foramen Ovale
10%
Idiopathic Pulmonary Arterial Hypertension
9%
Hazard Ratio
9%
ST-elevation Myocardial Infarction (STEMI)
8%
Voglibose
8%
Clinical Outcomes
8%
Implantable Cardioverter-defibrillator Shock
7%
High Risk
7%
Type 2 Diabetic Patients
7%
Severe Pulmonary Arterial Hypertension
7%
Pulmonary Artery Smooth muscle Cells (PASMCs)
7%
Cardiac Events
7%
Pulmonary Artery
7%
Contrast-induced Acute Kidney Injury (CI-AKI)
6%
Randomized Controlled Trial
6%
Coronary Artery Calcium Score
6%
Coronary Artery Disease
6%
Defibrillator
6%
T-wave Alternans
6%
Reverse Remodeling
6%
Pilsicainide
6%
Atrial Septal Defect
6%
